全文获取类型
收费全文 | 3367558篇 |
免费 | 244703篇 |
国内免费 | 8750篇 |
专业分类
耳鼻咽喉 | 46859篇 |
儿科学 | 112150篇 |
妇产科学 | 94929篇 |
基础医学 | 477334篇 |
口腔科学 | 94349篇 |
临床医学 | 302918篇 |
内科学 | 657238篇 |
皮肤病学 | 79081篇 |
神经病学 | 273527篇 |
特种医学 | 130853篇 |
外国民族医学 | 1047篇 |
外科学 | 509380篇 |
综合类 | 69357篇 |
现状与发展 | 6篇 |
一般理论 | 1192篇 |
预防医学 | 256938篇 |
眼科学 | 76725篇 |
药学 | 249195篇 |
9篇 | |
中国医学 | 6795篇 |
肿瘤学 | 181129篇 |
出版年
2018年 | 36136篇 |
2017年 | 27620篇 |
2016年 | 31954篇 |
2015年 | 36115篇 |
2014年 | 49759篇 |
2013年 | 75122篇 |
2012年 | 100076篇 |
2011年 | 106258篇 |
2010年 | 63997篇 |
2009年 | 61188篇 |
2008年 | 99971篇 |
2007年 | 106641篇 |
2006年 | 108642篇 |
2005年 | 104540篇 |
2004年 | 100703篇 |
2003年 | 97481篇 |
2002年 | 94615篇 |
2001年 | 158027篇 |
2000年 | 161946篇 |
1999年 | 136942篇 |
1998年 | 39752篇 |
1997年 | 35261篇 |
1996年 | 35515篇 |
1995年 | 34178篇 |
1994年 | 31628篇 |
1993年 | 29513篇 |
1992年 | 107874篇 |
1991年 | 104654篇 |
1990年 | 101872篇 |
1989年 | 98700篇 |
1988年 | 90893篇 |
1987年 | 89266篇 |
1986年 | 84219篇 |
1985年 | 80488篇 |
1984年 | 59759篇 |
1983年 | 51256篇 |
1982年 | 30476篇 |
1981年 | 27068篇 |
1979年 | 54166篇 |
1978年 | 38189篇 |
1977年 | 32702篇 |
1976年 | 30479篇 |
1975年 | 32922篇 |
1974年 | 38795篇 |
1973年 | 37029篇 |
1972年 | 35144篇 |
1971年 | 32549篇 |
1970年 | 30357篇 |
1969年 | 29139篇 |
1968年 | 27028篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
71.
Madan M. Rehani Emily R. Melick Raza M. Alvi Ruhani Doda Khera Salma Batool-Anwar Tomas G. Neilan Michael Bettmann 《European radiology》2020,30(4):1839-1846
To determine percent of patients without malignancy and ≤ 40 years of age with high cumulative radiation doses through recurrent CT exams and assess imaging appropriateness. From the cohort of patients who received cumulative effective dose (CED) of ≥ 100 mSv over a 5-year period, a sub-set was identified with non-malignant disease. The top 50 clinical indications leading to multiple CTs were determined. Clinical decision support (CDS) system scores were analyzed using a widely adopted standard of 1–3 (red) as “not usually appropriate,” 4–6 (yellow) “may or may not be appropriate,” and 7–9 (green) “usually appropriate.” Clinicians reviewed patient records to assess compliance with appropriate use criteria (AUC). 9.6% of patients in our series were with non-malignant conditions and 1.4% with age ≤ 40 years. CDS scores (rounded) were 2% red, 38% yellow, 27% green, and 33% unscored CTs. Clinical society guidelines for CT exams, wherever available, were followed in 87.5 to 100% of cases. AUCs were not available for several clinical indications as also referral guidelines for serial CT imaging. More than half of CT exams were unrelated to follow-up of a primary chronic disease. We are faced with a situation wherein patients in age ≤ 40 years require or are thought to require many CT exams over the course of a few years but the radiation risk creates concern. There is a fair number of conditions for which AUC are not available. Suggested solutions include development of CT scanners with lesser radiation dose and further development of appropriateness criteria. 相似文献
72.
73.
74.
75.
76.
Michael Staehler Peter J. Goebell Lothar Müller Till-Oliver Emde Natalie Wetzel Lisa Kruggel Martina Jänicke Norbert Marschner the RCC-Registry Group 《International journal of cancer. Journal international du cancer》2020,146(5):1307-1315
Non-clear cell renal cell carcinoma is a very rare malignancy that includes several histological subtypes. Each subtype may need to be addressed separately regarding prognosis and treatment; however, no Phase III clinical trial data exist. Thus, treatment recommendations for patients with non-clear cell metastatic RCC (mRCC) remain unclear. We present first prospective data on choice of first- and second-line treatment in routine practice and outcome of patients with papillary mRCC. From the prospective German clinical cohort study (RCC-Registry), 99 patients with papillary mRCC treated with systemic first-line therapy between December 2007 and May 2017 were included. Prospectively enrolled patients who had started first-line treatment until May 15, 2016, were included into the outcome analyses (n = 82). Treatment was similar to therapies used for clear cell mRCC and consisted of tyrosine kinase inhibitors, mechanistic target of rapamycin inhibitors and recently checkpoint inhibitors. Median progression-free survival from start of first-line treatment was 5.4 months (95% confidence interval [CI], 4.1–9.2) and median overall survival was 12.0 months (95% CI, 8.1–20.0). At data cutoff, 73% of the patients died, 6% were still observed, 12% were lost to follow-up, and 9% were alive at the end of the individual 3-year observation period. Despite the lack of prospective Phase III evidence in patients with papillary mRCC, our real-world data reveal effectiveness of systemic clear cell mRCC therapy in papillary mRCC. The prognosis seems to be inferior for papillary compared to clear cell mRCC. Further studies are needed to identify drivers of effectiveness of systemic therapy for papillary mRCC. 相似文献
77.
Niamh M. Kelly Jessica V. Keane Rachel B. Gallimore Debra Bick Rachel M. Tribe 《Maternal & child nutrition》2020,16(2)
There is evidence that caesarean section delivery can impact on neonatal weight loss and weight gain patterns in the first 5 days of life. We conducted an integrative systematic review to examine the association of mode of delivery on early neonatal weight loss. Pubmed, Cumulative Index to Nursing and Allied Health Literature, Web of Science, Excerpta Medica dataBASE, and Medical Literature Analysis and Retrieval System Online were searched for relevant papers published before June 2019. Reference lists from the relevant papers were then backwards and forwards searched. As neonatal weight loss was reported in different formats, a meta‐analysis could not be carried out. Most studies did not distinguish between elective and emergency caesarean sections or instrumental and nonassisted vaginal deliveries. Seven papers were included. All papers except one found that caesarean section was associated with higher weight loss in the early days of life. Two papers presented data from studies on babies followed up to 1 month. One study found that on day 25, babies born by caesarean section had significantly higher weight gain than those born vaginally, while another found that by day 28, babies born vaginally gained more weight per day (11.9 g/kg/day) than those born by caesarean section (10.9 g/kg/day; p = .02). Overall, infants born by caesarean section lost more weight than those born vaginally, but due to the small number of studies included, more are needed to look at this difference and why it may occur. This discrepancy in weight between the two groups may be corrected over time, but future studies will need larger sample sizes and longer follow‐up periods to examine this. 相似文献
78.
79.
80.